3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 4
1
Phase 1
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
87
Carcinoma, Non-Small-Cell Lung
76
Breast Neoplasms
73
Recurrence
64
Colorectal Neoplasms
63
Pancreatic Neoplasms
60
Melanoma
58
Advanced Solid Tumor
57
Carcinoma, Hepatocellular
56
Multiple Myeloma
55
Lymphoma
53
Leukemia, Myeloid, Acute
53
Advanced Solid Tumors
53
Neoplasm Metastasis
50
Stomach Neoplasms
47
Precursor Cell Lymphoblastic Leukemia-Lymphoma
44
Lymphoma, B-Cell
40
Solid Tumor
39
Ovarian Neoplasms
38
Lymphoma, Non-Hodgkin
38
Lung Neoplasms
36
Glioblastoma
35
Prostatic Neoplasms
34
Leukemia
28
Head and Neck Neoplasms
27
Leukemia, Lymphocytic, Chronic, B-Cell
26
Uterine Cervical Neoplasms
25
Burkitt Lymphoma
24
Esophageal Neoplasms
23
Urinary Bladder Neoplasms
20
Interventions
palbociclib
1
Rivaroxaban
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Unknown
×
Thrombosis
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled